IMCD NV (MEX:IMCDN) ROE %: 8.62% (As of Dec. 2025) — 34% Below Median


MEX:IMCDN IMCD NV MEX:IMCDN
80 GF Score
Price MXN1,965.20
GF Value MXN3,536.63
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is IMCD NV ROE %?

IMCD NV MEX:IMCDN 80 ROE % is 8.62% as of Dec. 2025, which is 34% below its 10-year median of 13.14. GuruFocus rates MEX:IMCDN with a GF Score™ of 80/100 and a GF Value™ of MXN3,536.63 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,591 Chemicals companies, IMCD NV ranks better than 74.04% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. IMCD NV's annualized net income for the quarter that ended in Dec. 2025 was MXN3,705 Mil. IMCD NV's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was MXN42,967 Mil. Therefore, IMCD NV's annualized ROE % for the quarter that ended in Dec. 2025 was 8.62%.

The historical rank and industry rank for IMCD NV's ROE % or its related term are showing as below:

MEX:IMCDN' s ROE % Range Over the Past 10 Years
Min: 10.23   Med: 13.14   Max: 19.99
Current: 10.48

During the past 13 years, IMCD NV's highest ROE % was 19.99%. The lowest was 10.23%. And the median was 13.14%.

MEX:IMCDN's ROE % is ranked better than
74.04% of 1591 companies
in the Chemicals industry
Industry Median: 5.19 vs MEX:IMCDN: 10.48

IMCD NV  (MEX:IMCDN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=3705.168/42966.53
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(3705.168 / 97206.956)*(97206.956 / 99106.2675)*(99106.2675 / 42966.53)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.81 %*0.9808*2.3066
=ROA %*Equity Multiplier
=3.74 %*2.3066
=8.62 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=3705.168/42966.53
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (3705.168 / 4931.58) * (4931.58 / 6450.806) * (6450.806 / 97206.956) * (97206.956 / 99106.2675) * (99106.2675 / 42966.53)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7513 * 0.7645 * 6.64 % * 0.9808 * 2.3066
=8.62 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


IMCD NV ROE % Related Terms


IMCD NV ROE % Historical Data

* Premium members only.

The historical data trend for IMCD NV's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMCD NV ROE % Chart

IMCD NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.98 18.91 16.28 15.14 10.04

IMCD NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.48 16.77 14.44 12.35 8.62

MEX:IMCDN vs LIN, SHW, ECL: ROE % Comparison

For the Specialty Chemicals subindustry, IMCD NV's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMCD NV ROE % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, IMCD NV's ROE % distribution charts can be found below:

* The bar in red indicates where IMCD NV's ROE % falls into.


MEX:IMCDN
80GF Score
IMCD NV MEX:IMCDN
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IMCD NV ROE % Calculation

IMCD NV's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=4587.405/( (48344.168+43029.87)/ 2 )
=4587.405/45687.019
=10.04 %

IMCD NV's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=3705.168/( (42903.19+43029.87)/ 2 )
=3705.168/42966.53
=8.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 8.62% mean?
IMCD NV (MEX:IMCDN) has a ROE % of 8.62% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on IMCD NV and its competitors. This is 34% below median its historical median of 13.14. Over the past decade, IMCD NV's ROE % has ranged from 10.23 to 19.99. According to the industry distribution chart, IMCD NV ranks #413 out of 1591 companies in the Chemicals industry, placing it in the top 26%.
Is IMCD NV's ROE % too high?
IMCD NV's current ROE % of 8.62% is 34% below median its 10-year median of 13.14. Over the past 10 years, this metric has ranged from a low of 10.23 to a high of 19.99. The Chemicals industry median ROE % is 5.19. IMCD NV's value of 8.62% is 66.1% above this industry median. Based on the distribution chart, IMCD NV ranks #413 out of 1591 companies in the Chemicals industry, which is above the industry midpoint. Overall, IMCD NV has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, IMCD NV ranks #413 out of 1591 companies for ROE %. This puts IMCD NV in the upper half of its industry. The industry median ROE % is 5.19. IMCD NV's value of 8.62% is 66.1% above this benchmark. Historically, IMCD NV's own ROE % has ranged from 10.23 to 19.99 over the past decade. While the company's 10-year median is 13.14 vs. the industry median of 5.19, IMCD NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.19, based on 1,591 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IMCD NV's current ROE % of 8.62% is 66.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on IMCD NV and its competitors. For the Chemicals industry, the median ROE % is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMCD NV's current ROE % is 8.62%, which is 34% below median its own 10-year median of 13.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (MEX:IMCDN) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN3,536.63, compared to a current price of MXN1,965.20 — trading 44.4% below its estimated fair value. The current ROE % is 8.62%, which is 34% below median its 10-year median of 13.14 and 66.1% above the Chemicals industry median of 5.19. IMCD NV's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For IMCD NV (MEX:IMCDN), the current ROE % is 8.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IMCD NV (MEX:IMCDN) Overvalued in 2026?

Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued. The current stock price of MXN1,965.20 is trading 44.4% below its estimated GF Value™ of MXN3,536.63. GuruFocus considers IMCD NV to be Significantly Undervalued.

Key valuation signals for MEX:IMCDN:

  • ROE %: 8.62% (34% below median its 10-year median of 13.14)
  • GF Value™: MXN3,536.63 vs. price of MXN1,965.20 (44.4% below fair value)
  • GF Score™: 80/100 with 4 warning signs
  • Industry Position: 66.1% above the Chemicals median (#413 of 1591)

No single metric tells the full story. See the MEX:IMCDN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IMCD NV Business Description

Address Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
80GF Score

Get the complete analysis for MEX:IMCDN

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,965.20
Price
MXN3,536.63
GF Value